Kristen O'Shaughnessy is a litigation partner in White & Case's New York office and a member of the Firm's Global Competition and Antitrust Group, which was named Competition Group of the Year seven timesby Law360. Ms. O'Shaughnessy's practice focuses on complex antitrust litigation and counseling, and she regularly represents global pharmaceutical companies (including Allergan, Boehringer Ingelheim, and Pfizer) in "bet the company" cases on the cutting edge of antitrust and intellectual property. She also has experience representing clients in the health insurance, automotive, and oil and gas industries.
Ms. O'Shaughnessy is a leader in the firm's Women's Initiative, involved in coordinating female mentoring, networking events, and community outreach.
Prior to joining White & Case, Ms. O'Shaughnessy worked in Thailand advising clients on international intellectual property issues, including counseling the Thai Department of Intellectual Property on compliance with the Madrid Protocol and assisting a major pharmaceutical company with its global patent litigation strategy.
Ms. O'Shaughnessy holds a degree in engineering from Northwestern University.
Member of trial team representing Anthem, Inc. in its defense at an expedited trial and on expedited appeal against claims brought by the US Department of Justice to block Anthem's US$54 billion acquisition of Cigna Corporation.
Member of trial team representing a global pharmaceutical company in a preliminary injunction hearing in the Southern District of New York in an antitrust action challenging a new-product launch.
Representation of several leading innovator pharmaceutical manufacturers in multiple class action antitrust challenges to patent settlement agreements and other business arrangements between innovator and generic manufacturers.
Representation of a leading innovator pharmaceutical manufacturer in class action antitrust challenges to new product launches.
Counseling to Kenyan company for compliance with Foreign Corrupt Practices Act, and representation in an anti-corruption audit.
Representation of company executives in the automotive and oil and gas industries in criminal investigations by the US Department of Justice.
Submission of an amicus brief to the United States Supreme Court in Kirtsaeng v. John Wiley & Sons on behalf of major national art museums, pertaining to museums' rights under the Copyright Act to display lawfully owned works of art. The Supreme Court cited the amicus brief in support of its landmark decision that the "first sale" doctrine applies to foreign-manufactured goods. The National Law Journal featured the brief as its "brief of the week" on July 25, 2012.
Assistant editor of the ABA Monopolization and Dominance Handbook, addressing the antitrust rules and principles governing unilateral business conduct.
"Recent Antitrust Developments: March and April 2015", May 12, 2015: ABA Section of Antitrust Law, Health Care and Pharmaceuticals Committee
United States: Pharmaceutical Antitrust 2019, Global Competition Review, Sept. 2018, (co-author with Michael Gallagher, Eric Grannon, Heather McDevitt, Kevin Adam, Adam Acosta, and Trisha Grant)
United States: Pharmaceutical Antitrust 2018, Global Competition Review, Sept. 2017, (co-author with Michael Gallagher, Eric Grannon, Heather McDevitt, Kevin Adam, Adam Acosta, and Trisha Grant)
United States: Pharmaceutical Antitrust 2017, Global Competition Review, Sept. 2016, (co-author with Michael Gallagher, Eric Grannon, Heather McDevitt, Kevin Adam, Adam Acosta, and Trisha Grant)
United States: Pharmaceutical Antitrust 2016, Global Competition Review, Sept. 2015, (co-author with Eric Grannon, Heather McDevitt, Adam Acosta, and Trisha Grant)
Best Antitrust Business Article – Intellectual Property Category, Concurrences Antitrust Writing Awards (2018)
Pro Bono Honor Roll, White & Case, 2011, 2012, 2013, 2018
Pro Bono Award for Outstanding Legal Service, White & Case, 2012